Healthtech Startups

CathVision develops electrophysiology solutions for physicians treating cardiac arrhythmia, including the ECGenius EP recording system for cardiac signal acquisition and Cardialytics AI-based analytic tools. Its products support the diagnosis, characterization, and treatment of heart rhythm disorders in the EP lab.

1 investor

CatSci is a contract research organization (CRO) providing drug development services — including catalyst screening, process chemistry, analytical development, oligonucleotides, peptides, and bioscience — to help biotech and pharma companies advance complex synthetic medicines from discovery to IND. It operates 14 laboratories across the UK and Europe and serves more than 100 biotech and global pharma customers.

1 investor

Cavendish operates a peer-to-peer community connecting health and life sciences innovators with family offices, foundations, philanthropists, and impact investors to fund projects between proof-of-concept and commercialization. It offers forums and summits, a digital community, advisory services, and access to experts and capital sources focused on impact investing and sustainable philanthropy.

1 investor

Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.

1 investor

CBSET is a preclinical translational research institute that provides GLP-compliant, AAALAC-accredited contract research services—including vivaria, imaging labs, surgical suites, histopathology, and pathology—for medical device, pharmaceutical, and academic sponsors. It supports clients' regulatory filings and product development from its facilities in the greater Boston area.

1 investor

CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision. The company uses its proprietary Zeus platform to discover and optimize first-in-class treatments for patients seeking alternatives to antibiotics.

1 investor

The company produces cosmetic covers (silicone-like coverings) for lower-limb prostheses, serving amputees and prosthetic centers in Russia. Customers can obtain the covers via a state electronic certificate through the Gosuslugi portal or by ordering directly through their prosthetic center.

1 investor

Cebina is an early-stage biotech investor and incubator that funds and de-risks pre-company and startup drug development projects across pre-seed, seed, and Series A stages. It focuses on therapeutic areas including cardiovascular and metabolic diseases, lung fibrosis, cancer immunotherapy, and anti-infectives, and also pursues co-development and licensing partnerships.</parameter> <parameter name="founders">[]

1 investor

Cedar Health Research operates clinical research services for community-based healthcare providers, connecting patient populations with clinical trials through partnerships and EMR abstraction technology. The company aims to ensure clinical trial participants reflect the broader patient population bearing disease burden.

1 investor

CEDCAS is a Christian nonprofit organization operating since 1985 that promotes community health through preventive care and education, supporting organized women's community groups and their formation into associations. It runs individual and organizational health programs, a community health center (Casa Salud), and a clinic offering medical, dental, and specialty services.

1 investor

Cell Invent develops human disease models using reprogrammed Alzheimer patient cells to identify new therapeutic approaches for Alzheimer's disease. The company applies proprietary cellular research technology from Lund University to drug discovery and disease modeling for the neurodegenerative disease market.

1 investor

CellaraRx develops Horizen, a platform that uses single-cell RNA sequencing, digital pathology, and AI to help clinicians and drug developers predict patient response to cancer treatments before clinical trial enrollment. The platform identifies tumor resistance mechanisms and tissue drug accessibility to improve patient stratification and trial success rates.

1 investor

Cellari develops regulatory-approved AI software and accompanying hardware for medical imaging, offering tools for pixel-precise annotation, dataset management, on-network data analysis, and cloud-based model training. It serves clinics, pharmaceutical and med-tech companies, and research organizations, with data stored on European servers under regulatory data standards.

1 investor

CellaVision is a provider of digital hematology microscopy solutions including analyzers, instruments, reagents, and software that automate workflow in hematology laboratories. The company serves clinical and veterinary laboratories globally with digital cell morphology tools to minimize human error and streamline data management.

1 investor

Cellbox Solutions develops portable incubators with active CO₂ and temperature control to transport living cells and biological samples at constant laboratory conditions (37°C, 5% CO₂). The company serves the global biomedical industry and works with over 150 customers on cell transport logistics.

1 investor

CellBri provides modular, automated cell processing systems for preparing cells for therapeutic applications. The company offers enclosed, turnkey solutions that can automate individual steps or complete workflows, from cell harvesting and separation through expansion and cryopreservation.

1 investor

CellCarta is a contract research organization providing biomarker discovery, assay development, and clinical trial execution services for pharmaceutical companies and biotechs. It offers multi-omic biomarker insights, regulatory-ready data generation, and regulatory support for assay development and IVDR submissions across preclinical and clinical therapeutic programs.

1 investor

Cellcolabs manufactures bone marrow-derived mesenchymal stem cells (MSCs) at industrial scale using its GMP-certified Cellcolabs Protocol, a standardized and validated production process. The company supplies pharmaceutical-grade stem cells to support clinical research and global collaborations in the field of advanced cell therapies.

1 investor

Celldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.

1 investor

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellera Farma is a Brazilian pharmaceutical company that manages a portfolio of established medical products through partnerships, licensing, distribution, promotion, and proprietary products. It focuses on therapeutic areas including central nervous system, gastroenterology, orthopedics, and pediatrics.

1 investor

Cellergy Pharma develops immunotherapies for patients with severe allergic disease and cancer.

1 investor

IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.

1 investor

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor